Insomnia has a major impact on human health, performance, economic productivity and quality of life. 1,2 Insomnia chronic or severe enough to merit treatment occurs in 8-14% of the general population. 3 There are few specialised sleep clinics in Great Britain other than respiratory ones (eg for obstructive sleep apnoea syndrome (OSAS)), most clinicians do not have easy access to psychological treatments, and very often the simplest course of action is the prescription of hypnotic drugs. However, the appropriate use of hypnotics requires an accurate diagnosis of the sleep disorder and knowledge of the pharmacokinetics and dynamics of the available drugs. The length of total sleep in a day varies in normal adults, with an average of 7-8 hours in the 20-45 year age group. Sleep time and sleep continuity are decreased in older people and increased daytime napping often leads to a further reduction in the night-time sleep. A normal subject has several short awakenings during the night, most of which are not perceived as awakenings unless they last more than about two minutes. There will probably not be clear consciousness, but subjects may have occasional brief thoughts of how comfortable they feel or how pleased they are that it is not yet time to get up, with an immediate return to sleep. If during the short period of waking some factor causes anxiety or anger (eg aircraft noise, partner's snores or dread of being awake), progress to full awakening and remembering this awakening in the morning are much more likely. The more often this happens, the more subjects complain of unrefreshing sleep. Perhaps the most common cause of irritation derives from 'clock watching': subjects check the time on awakening, remember it and repeat this cycle many times during the night, neglecting periods of sleep in between. This produces anger and frustration, which in turn delay return to sleep and may promote subsequent awakenings.
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Diagnosing insomnia
Insomnia is the complaint of poor sleep, with a patient reporting that the duration or subjective quality of sleep is unsatisfactory. It is often accompanied by daytime fatigue, but not usually by daytime sleepiness -it seems that the factors that keep people awake at night also serve to keep them awake in the day. To aid diagnosis of sleep disorders it is important for patients to keep a diary of when they slept and how they felt about their sleep. Some questions to ask patients to help determine the nature and type of their insomnia are shown in Table 1 .
It is important to exclude other sleep disorders as a cause of insomnia, particularly restless legs syndrome, usually associated with periodic leg movements in sleep, and parasomnias such as night terrors and sleepwalking. Referral to a specialist sleep centre for objective recording of sleep may be necessary if the presentation is unusual or diagnosis is in doubt, and actigraphy (Fig 1) or polysomnography may be used.
Some precipitating factors in insomnia are listed in Table 2 . Timely treatment of short-term insomnia is valuable as it may prevent progression to a chronic condition which is much harder to alleviate. Psychological treatments are effective, 4 while pharmacotherapy may be either unnecessary or used as a short-term adjunct. The approaches of treatment are to:
• treat any precipitating cause if possible • establish good sleep habits ( Table 3) • reassure that sleep will improve • consider hypnotic medication.
Long-term insomnia
There are various reasons why insomnia can progress to become a long-term problem. The most common are:
• poor sleep hygiene has been established and continues
• the patient has become excessively anxious about their sleep, spending much time and effort on 'trying' to sleep.
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The most important factor in the treatment of long-term insomnia is anxiety about sleep, arising from conditioning behaviours that predispose to heightened arousal and tension at bedtime. Thus the bedroom is associated with not sleeping and automatic negative thoughts about the sleeping process occur in the evening.
Cognitive behavioural therapy
A helpful treatment approach to anxiety about sleep is cognitive behavioural therapy which, together with education and sleep hygiene measures as above, is the treatment of choice for long-term primary insomnia. 5 However, the availability of these therapies is often limited and some patients are unwilling or unable to engage with them.
Drugs for insomnia
Most drugs used in insomnia act as agonists at the gamma-aminobutyric acid (GABA)-A-benzodiazepine receptor and have effects other than their direct sedating action, including muscle relaxation, memory impairment and ataxia, which can impair performance of skills such as driving. Those drugs with longer duration of action are likely to affect psychomotor performance, memory and concentration, and will also have enduring anxiolytic and muscle-relaxing effects.
Hypnotics acting at the benzodiazepine receptor
All benzodiazepines and newer benzodiazepine-like ('Z') drugs are safe and effective for insomnia -if the compound with the right timing of onset of action and elimination is chosen. Care should be taken in prescribing them to patients with comorbid sleep-related breathing disorders such as obstructive sleep apnoea syndrome which is exacerbated by benzodiazepines. It is important to stress that alcohol potentiates the effects of these drugs: patients should be made aware that if they have a drink in the evening, their sleeping pill will have greater and longer-lasting effects which may have an impact on driving the next day. The choice of drug should be determined by pharmacokinetic properties.
A variety of benzodiazepines to treat insomnia is available in UK. The shortest-acting are temazepam, loprazolam and lormetazepam, with half-lives of up to 12 hours. Zopiclone has a half-life of 6-8 hours, making it an effective drug both for initial and maintenance insomnia. Zolpidem and zaleplon have a fast onset (30-60 min) and short durations of action, with half-lives of three hours and two hours, respectively (Fig 2) .
Studies of psychomotor performance in volunteers have shown that zaleplon has no effect on psychomotor skills, including driving skills, when taken at least five hours before testing. Thus, it can be taken during the night, either when patients have tried getting off to sleep for a long time or if they wake during the night and cannot return to sleep, without hangover effect. It is the only prescribable hypnotic that can be used in this way. Table 2 . Some precipitating factors in insomnia.
Hypnotics: tolerance and dependence
• Keep regular bedtimes and rising times • Reduce daytime napping
• Daytime (but not evening) exercise and exposure to daylight (especially morning sun) are beneficial
• Avoid stimulants, alcohol and cigarettes in evening
• Establish bedtime routine ('wind down'), use some time in early part of evening to write down any residual issues from the current day as well as plans for the coming one
• Avoid dwelling on problems in bed
• Bed should be comfortable and not too warm or too cold Antidepressants. There is no objective evidence that very low doses of tricyclic antidepressants improve sleep in primary insomnia. In depression, mirtazapine is useful in patients with marked insomnia as a symptom.
Melatonin. Melatonin, the hormone produced by the pineal gland during darkness has been investigated for insomnia but it appears to be ineffective, although it seems to help in alleviating jet lag. 
